X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/partner-therapeutics-leukine-sargramostim-receives-approval-in-japan-to-treat-autoimmune-pulmonary-alveolar-proteinosis-apap-302107763.html
https://www.prnewswire.com/news-releases/comprehensive-review-highlights-importance-of-leukine-in-combination-with-anti-gd2-immunotherapy-for-treatment-of-high-risk-pediatric-neuroblastoma-302037532.html
https://www.prnewswire.com/news-releases/exploratory-results-suggest-the-potential-role-of-leukine-as-a-host-directed-immunomodulator-302020419.html
https://www.prnewswire.com/news-releases/partner-therapeutics-announces-publication-of-a-retrospective-cohort-review-of-15-leukine-treated-patients-with-pediatric-malignancies-and-invasive-fungal-disease-refractory-to-antifungal-therapy-301704560.html
https://www.prnewswire.com/news-releases/partner-therapeutics-announces-publication-of-results-from-pre-clinical-study-evaluating-recombinant-murine-gm-csf-in-mouse-models-of-down-syndrome-and-normal-aging-301513066.html
https://www.prnewswire.com/news-releases/barda-and-partner-therapeutics-foster-a-new-partnership-around-their-fda-approved-drug-leukine-to-improve-patient-care-for-sepsis-patients-301380227.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-21-2021-1626855243.pdf
https://www.partnertx.com/partner-therapeutics-announces-publication-of-clinical-trial-results-of-leukine-sargramostim-in-patients-with-parkinsons-disease/
https://www.prnewswire.com/news-releases/partner-therapeutics-initiates-patient-enrollment-in-clinical-trial-evaluating-leukine-rhugm-csf-sargramostim-in-high-risk-non-hospitalized-covid-19-patients-scope-301280272.html
Market Place
Share 
